期刊文献+

半乳糖凝集素3在慢性阻塞性肺疾病患者中的水平变化及意义 被引量:2

Changes and significance of Galectin-3 in patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的观察半乳糖凝集素3(Galectin-3)在慢性阻塞性肺疾病(COPD)患者中的水平变化,探讨其与肺功能指标、炎性因子水平的关系。方法分别选取40例COPD患者作为观察组、40例健康体检人员作为对照组,检测并比较2组研究对象Galectin-3、炎性因子水平、肺功能情况。结果观察组Galectin-3、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP)水平均显著高于对照组(P <0.05);观察组肺功能指标水平显著低于对照组,差异有统计学意义(P <0.05);AECOPD患者Galectin-3水平与hs-CRP、TNF-α、IL-6水平均呈正相关性(P <0.01),与用力肺活量(FVC)、1 s用力呼气容积(FEV1)、FEV1/FVC等肺功能指标均呈负相关性(P <0.05);治疗后,AECOPD患者Galectin-3水平较治疗前明显降低(P <0.05),差异有统计学意义。结论 AECOPD患者体内Galectin-3水平较高,与炎性因子、肺功能相关,可作为AECOPD病情评估的辅助观察指标。 Objective To investigate the level changes of Galectin-3 in patients with chronic obstructive pulmonary disease( COPD),and to investigate the relationship between lung function index and inflammatory factors. Methods A total of 40 patients with COPD admitted to our hospital were selected as subjects,40 health examiners were selected as controls.Galectin-3 level,inflammatory factor and lung function were compared between the two groups. Results The levels of Galectin-3,hs-CRP,TNF-α and IL-6 in the observation group were significantly higher than those in the control group( P <0. 05). The levels of FVC,FEV1 and FEV1/FVC in the observation group were significantly lower than those in the control group,with the differences statistically significant( P < 0. 05). Pearson correlation analysis showed that Galectin-3 levels were positively correlated with hs-CRP,TNF-α,and IL-6 levels( P < 0. 01),while Galectin-3 levels were negatively correlated with FVC,FEV1,and FEV1/FVC levels( P < 0. 05). After treatment,the level of Galectin-3 in AECOPD patients was significantly lower than before treatment,with the differences statistically significant( P < 0. 05). Conclusion The level of Galectin-3 in patients with COPD is high,and it is related to inflammatory factors and lung function. Galectin-3 can be used as an auxiliary observation indicator for the disease severity assessment of AECOPD.
作者 毛建华 王慧芬 杨利萍 MAO Jian-hua;WANG Hui-fen;YANG Li-ping(Pneumology Department,Quzhou Hospital of Tradional Chinese Medicine,Quzhou,Zhejiang 324000,China)
出处 《中国卫生检验杂志》 CAS 2020年第22期2768-2770,2773,共4页 Chinese Journal of Health Laboratory Technology
关键词 慢性阻塞性肺疾病 半乳糖凝集素3 炎性因子 肺功能 Chronic obstructive pulmonary disease Galectin-3 Inflammatory factor Pulmonary function Disease severity assessment
  • 相关文献

参考文献12

二级参考文献87

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2024
  • 2徐文辉,朱坚华.缓解期COPD患者血清粒细胞集落刺激因子的变化及其与肺功能的关系[J].实用医学杂志,2006,22(9):1031-1032. 被引量:2
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 4金永堂,周晓铁.慢性阻塞性肺部疾病的家族聚集性分析[J].中华预防医学杂志,1997,31(2):107-108. 被引量:6
  • 5Keating GM, McCormack PL. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease ~J~. Drugs, 2007, 67(16): 2383-2405.
  • 6Ford PA, Durham AL, Russell RE, et al. Treatment effects of low - dose theophylline combined with an inhaled eorticosteroid in COPD [J]. Chest, 2010, 137(6): 1338 -1344.
  • 7Canavan J L, Moreton-Clack M, Lewko A, et al. S30 An evalua- tion of the systemic inflammatory response to endurance walking in patients with COPD: comparison with healthy individuals [ J ]. Tho- rax, 2011, 66(14): 16-17.
  • 8Chen C, Shen Y, Ni CJ, et al. Imbalance of circulating T - lympho- cyte subpopulation in COPD and its relationship with CAT perform- anee[J]. J Clin Lab Anal. 2012. 26(2) : 109 -114.
  • 9Dirk J. A. Lok,Peter Meer,Pieta W. Bruggink-André Porte,Erik Lipsic,Jan Wijngaarden,Hans L. Hillege,Dirk J. Veldhuisen.Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study[J]. Clinical Research in Cardiology . 2010 (5)
  • 10Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure:recent advances in basicscience [ J ]. Lancet, 2011,378 ( 9792 ) : 704 - 712.

共引文献419

同被引文献28

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部